Applications

1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Deferred

Application details

Reason for application

-

Service or technology in this application

-

Medical condition this application addresses

-

Application documents

PICO confirmation

Public summary document – August 2012

Public summary document – August 2013

Predicted versus actual

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Meetings to consider this application

  • PASC meeting: 
    • 14 - 15 September 2011
    • 1 - 2 December 2011
  • ESC meeting: -
  • MSAC meeting: 
    • 2 August 2012
    • 1 August 2013
    • 24-25 November 2016